HomeOCUL • NASDAQ
add
Ocular Therapeutix Inc
Previous close
$7.11
Day range
$7.03 - $7.64
Year range
$4.06 - $11.77
Market cap
1.20B USD
Avg Volume
1.93M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 17.08M | 15.41% |
Operating expense | 25.44M | 47.30% |
Net income | -48.39M | -65.60% |
Net profit margin | -283.27 | -43.49% |
Earnings per share | -0.29 | 17.14% |
EBITDA | -49.62M | -159.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 392.10M | 100.25% |
Total assets | 457.94M | 81.68% |
Total liabilities | 142.59M | -11.40% |
Total equity | 315.34M | — |
Shares outstanding | 159.02M | — |
Price to book | 3.56 | — |
Return on assets | -26.67% | — |
Return on capital | -30.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -48.39M | -65.60% |
Cash from operations | -39.43M | -75.60% |
Cash from investing | -202.00K | 55.99% |
Cash from financing | 4.51M | -95.83% |
Net change in cash | -35.12M | -141.19% |
Free cash flow | -23.92M | -50.47% |
About
CEO
Founded
2006
Headquarters
Website
Employees
274
